Business Wire
24 Jun 2026, 01:57 UTC · 2h ago
Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Business Wire
24 Jun 2026, 01:57 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
Definium Therapeutics priced an underwritten public offering of 20,588,236 common shares at $34.00 per share. — Public offerings typically create immediate downward pressure on stock prices due to equity dilution.
-0.40Which stocks this story touches
The company is raising significant capital through a public offering to fund its clinical development.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
3h ago
